L

Lytix Biopharma AS
OSE:LYTIX

Watchlist Manager
Lytix Biopharma AS
OSE:LYTIX
Watchlist
Price: 6.88 NOK 0.88% Market Closed
Market Cap: 341.3m NOK
Have any thoughts about
Lytix Biopharma AS?
Write Note

Lytix Biopharma AS
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lytix Biopharma AS
Cash from Financing Activities Peer Comparison

Comparables:
HBC
B
BGBIO
AZT
N
NYKD
T
TRMED

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
L
Lytix Biopharma AS
OSE:LYTIX
Cash from Financing Activities
-kr943k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Cash from Financing Activities
kr38.1m
CAGR 3-Years
-38%
CAGR 5-Years
-3%
CAGR 10-Years
-9%
B
Bergenbio ASA
OSE:BGBIO
Cash from Financing Activities
kr137.2m
CAGR 3-Years
67%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Cash from Financing Activities
-kr3.9m
CAGR 3-Years
-7%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
N
Nykode Therapeutics ASA
OSE:NYKD
Cash from Financing Activities
$43.7m
CAGR 3-Years
N/A
CAGR 5-Years
11%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Cash from Financing Activities
kr168k
CAGR 3-Years
-93%
CAGR 5-Years
-76%
CAGR 10-Years
-40%

See Also

What is Lytix Biopharma AS's Cash from Financing Activities?
Cash from Financing Activities
-943k NOK

Based on the financial report for Dec 31, 2023, Lytix Biopharma AS's Cash from Financing Activities amounts to -943k NOK.

What is Lytix Biopharma AS's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
-26%

Over the last year, the Cash from Financing Activities growth was -26%.

Back to Top